|Articles|March 1, 2013
- Pharmaceutical Executive-03-01-2013
- Volume 0
- Issue 0
PE, March 2013 Cover Image
S
Advertisement
Cover
Articles in this issue
over 12 years ago
Less Selling, More Timeover 12 years ago
Test and Learn: Making Confident Decisions on the Commercial Sideover 12 years ago
China and the Emerging Markets Challengeover 12 years ago
Embedding Market Access in Today's Pharma Business Modelover 12 years ago
Who's Really in Charge of European Drug Registration?over 12 years ago
Brand of the Year: Januviaover 12 years ago
Early Engagement with Medical Laboratoriesover 12 years ago
Pharma in the News: Pharm Exec's Annual Press Auditover 12 years ago
Safeguarding the Value of Patent AssetsNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Organon CEO Kevin Ali to Resign Following Internal Investigation into Nexplanon Sales
2
Study Claims Ozempic Lowers Biological Age
3
GSK Agrees to $357 Million Exclusive License Agreement for Syndivia’s AntiBody-Drug Conjugate
4
How will DTC Programs Impact PBMs?
5
